Nearly every woman with breast cancer has at least one menopausal symptom. Yet many patients feel their quality-of-life needs ...

Vaginal estrogen therapy does not increase the risk for recurrence in women with hormone receptor (HR)–negative breast cancer or in those with HR–positive tumors concurrently treated with tamoxifen ...

Women using a certain type of hormone therapy to treat menopause symptoms could be at higher risk for breast cancer, according to a new study. The study, published Tuesday in The Lancet Oncology, ...

Hormone therapy for breast cancer slows or stops the growth of hormone-sensitive tumors and is not the same as hormone replacement therapy.

Hormone therapy may be used by young women to relieve symptoms from hormone-­related conditions, menopause, or gynecologic surgery. Use of estrogen hormone therapy was inversely associated with ...

Proactive use of hormone therapy may help improve the quality of life and health of perimenopausal and menopausal women.

A difficult discussion with survivors of breast cancer is whether or not to use estrogen replacement for menopausal symptoms. No question, quality of life is improved in postmenopausal women post ...

SAN ANTONIO -- Menopausal hormone therapy (MHT) did not increase breast cancer risk in women with BRCA mutations, according to a study reported here. In fact, women who used estrogen-only MHT had a ...

EPT use is associated with increased risk of luminal-like breast cancer subtypes, especially in women with a healthy weight. ET use shows a lower occurrence of certain breast cancer subtypes in women ...

Faslodex (fulvestrant) is a prescription medicine used for people with certain types of breast cancer. Faslodex is given as an injection into the buttocks (gluteal area) by a health care provider in a ...